Safety and acceptability with the use of a contraceptive vaginal ring after surgical or medical abortion

Contraception

Volumn 75, Issue 5, 2007, Pages 367-371

  Fine, Paul M ^a   Tryggestad, Jennifer ^a   Meyers, Nancy J ^a   Sangi Haghpeykar, Haleh ^a  

^a Southeast Texas Cardiovascular   (United States)

Author keywords

Abortion; Acceptability; Contraceptive vaginal ring; Postabortion infection; Safety

Indexed keywords

ORAL CONTRACEPTIVE AGENT;

ABORTION; ACNE; ARTICLE; BARRIER CONTRACEPTION; CONTROLLED STUDY; EDEMA; FEMALE; FIRST TRIMESTER PREGNANCY; FOLLOW UP; HEADACHE; HORMONAL CONTRACEPTION; HUMAN; MAJOR CLINICAL STUDY; MIGRAINE; NAUSEA; PHYSICAL EXAMINATION; RISK ASSESSMENT; VAGINA RING;

ABORTION, INDUCED; ADULT; CONTRACEPTIVE DEVICES, FEMALE; FEMALE; HUMANS; PATIENT SATISFACTION; PREGNANCY; PREGNANCY TRIMESTER, FIRST;

EID: 34047267851     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.contraception.2007.01.009     Document Type: Article

References (14)

1. Finer L.B., and Henshaw S.K. Disparities in rates of unintended pregnancy in the United States, 1994 and 2001. Perspect Sex Reprod Health 38 (2006) 90-96
2. Skjeldestad F.E. The incidence of repeat induced abortion - a prospective cohort study. Acta Obstet Gynecol Scand 73 (1994) 706-710
3. Garg M., Singh M., and Mansour D. Peri-abortion contraceptive care: can we reduce the incidence of repeat abortions?. J Fam Plann Reprod Health Care 27 (2001) 77-80
4. Lesnewski R., and Prine L. Initiating hormonal contraception. Am Fam Physician 74 1 (2006) 105-112
5. Potter L., Oakley D., de Leon-Wong E., and Canamar R. Measuring compliance among oral contraceptive users. Fam Plann Perspect 28 (1996) 154-158
6. Roumen F.J., Apter D., Mulders T.M., and Dieben T.O. Efficacy, tolerability, and acceptability of a novel contraceptive vaginal ring releasing etonogestrel and ethinyl oestradiol. Hum Reprod 16 (2001) 469-475
7. Bjarnadóttir R.I., Tuppurainen M., and Killick S.R. Comparison of cycle control with a combined contraceptive vaginal ring and oral levonorgestrel/ethinyl estradiol. Am J Obstet Gynecol 186 (2002) 389-95
8. Westhoff C., Osborne L., Schafer J., and Morroni C. Bleeding patterns after immediate initiation of an oral compared with a vaginal hormonal contraceptive. Obstet Gynecol 106 (2005) 89-96
9. NuvaRing Physician's Insert 75137. http://www.nuvaring.com/authfiles/Images/309_76063.pdf
10. Novak A., de la Loge C., and Abez L. Development and validation of an acceptability and satisfaction questionnaire for a contraceptive ring. NuvaRing. Pharmacoeconomics 22 (2004) 245-256
11. Dieben T.O., Roumen F.J., and Apter D. Efficacy, cycle control, and user acceptability of a novel combined contraceptive vaginal ring. Obstet Gynecol 100 (2002) 585-593
12. Davis A., Westhoff C., and De Nonno L. Bleeding patterns after early abortion with mifepristone and misoprostol or manual vacuum aspiration. J Am Med Womens Assoc 55 Suppl (2000) 141-144
13. Alan Guttmacher Institute. Induced abortion [fact sheet]. Facts in brief, 2004 (2004). http://www.agi-usa.org/pubs/fb_induced_abortion.html Accessed December 10
14. Novak A., de la Loge C., Abetz L., and van der Muelen E.A. The combined contraceptive ring, NuvaRing: an international study of user acceptability. Contraception 67 (2003) 187-194